AH
ICVX

Andreas Halvorsen’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Andreas Halvorsen’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,796,800
Closed -$41.1M – 119
2021
Q4 		$41.1M Sell
1,796,800
-55,989
-3% -$1.45M 0.12% 91
2021
Q3 		$54.8M Buy
+1,852,789
New +$62.8M 0.15% 81

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Andreas Halvorsen's ICVX Position: Q1 2022 in Review

Andreas Halvorsen sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2022, closing a stake of 1,796,800 shares — an estimated $41.1M sold.

Andreas Halvorsen first reported a position in ICVX in Q3 2021 and held it in 2 quarters. The position peaked at $54.8M in Q3 2021. 65 funds tracked by Wall St. Rank hold ICVX as of Q1 2022.

  • Andreas Halvorsen reported no remaining Icosavax, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Andreas Halvorsen sold 1,796,800 Icosavax, Inc. Common Stock shares in Q1 2022, an estimated $41.1M.
  • Andreas Halvorsen first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Andreas Halvorsen's Icosavax, Inc. Common Stock position peaked at $54.8M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.